Purinergic Signal
Purinergic Signalling
1573-9538
1573-9546
Springer Netherlands
Dordrecht


2072910
18404440
9064
10.1007/s11302-007-9064-0
Original Paper


12
-like receptor group

Schöneberg
Torsten

+49-341-9722150
+49-341-9722159
schoberg@medizin.uni-leipzig.de

1

Hermsdorf
Thomas

1

Engemaier
Eva

1

Engel
Kathrin

1

Liebscher
Ines

1

Thor
Doreen

1

Zierau
Klaas

1

Römpler
Holger

1
2

Schulz
Angela

1

1
Institute of Biochemistry, Molecular Biochemistry, Medical Faculty, University of Leipzig, Johannisallee 30, 04103 Leipzig, Germany 
2
Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA USA 

6
9
2007

9
2007

3
4
255
268
6
7
2007

19
7
2007


© Springer Science + Business Media B.V. 2007

12
12
12
12
12
-like receptor members.

Keywords
Evolution
G protein-coupled receptor
Nucleotide receptor
Orphan GPCR

issue-copyright-statement
© Springer Science+Business Media B.V. 2007




Introduction
1
1, 2, 4, 6, 11–14
2
1
11
12
13
4
6
2
14
1
2
3
4
5
6
9
]. Recent success in expressing GPCR in yeast, which is discussed below, may circumvent these problems and may engage structure-function-relation studies.
1
10
1
12
1
12
. So we suggest that grouping of P2Y receptors should be performed on phylogenetic aspects rather than on ligand specificity.
1
1, 2, 4, 6, 11
12–14
1
4
12
11
12
13
1
6
14
12
Fig. 1
2
10
12
framed
1
2






12
-like GPCR
Discovery and deorphanization of group members
12
12
13
14
1
1
lyso
12
Table 1
12
-like receptor family

Receptor
G protein coupling
Natural agonist
Tissue expression


12

i

ADP, CysLT-E4, phosphoribosyl pyrophosphate
19
]

13

i

ADP, diadenosine triphosphate
22
45
]

14

i

N
-acetylglucosamine
15
16
71
]

GPR87
i

n.k
28
29
]

GPR171
n.k
n.k
n.k

GPR34
i

lyso
-phosphatidylserine
27
31
34
72
]

GPR82
n.k
n.k
Testes, epididymis (unpublished own results)



1
). Although they share structural features it appears from current studies that not all members are receptors for nucleotides. The table lists the currently known receptor agonists, the receptor’s G protein specificity and expression pattern
n.k
 not known



12
14
15
16
17
14
 by screening multiple receptors, each expressed in individual yeast strains, against a large library of over 700 known and putative natural GPCR agonists.
12
18
21
12
12
+
Xenopus
19
2+
12
21
13
12
22
24
12
N
1
12
13
25
].
26
27
28
29
30
12
1
lyso
31
12
-like receptors are still orphan GPCR.

The evolutionary origins
12
1
2
12
12
13
14
2
12
13
14
12
14
12
32
12
Fig. 2
12
12
-like receptors, the amino acid sequences of orthologs from one species of each vertebrate class (if available) were aligned using CLUSTAL W (identity matrices) and a phylogenetic tree was constructed (1,000 iterations). Bootstrap values >600 were considered as significant to support a new branch




12
14
Mustelus manazo
Carcharodon carcharias
Callorhinchus milii
12
Petromyzon marina
Strongylocentrotus purpuratus
12
Gnathostomata
 or, less likely, a loss in agnate and all non-vertebrates.
12
13
14
12
13
12
13
12
14
14
Xenopus
14
14
 gene loss in amphibians must be considered.
14
12
12
Anolis carolinensis
12
-like receptors which are less important in some species or are compensated by other receptors and mechanisms.
12
33
12
2
). Sequences with residual relation to the GPR34-like receptor are found in the platypus genome but it is most likely a pseudogene.

12
-like receptors
Comparison of transcript and genomic sequences provides information on intron/exon structure of a GPCR gene. Since the gain or loss of spliceosomal introns are unique events in evolution, they can serve as markers for phylogenetic analysis. Further, such analyses may reveal splice variants and may be informative about the promoter structure and gene regulation. Introns are the basis of alternative splicing, exon skipping, and RNA editing events and, therefore, can contribute to receptor diversity at a supragenomic level.
12
2
34
Table 2
12
n.a.
 not analyzed because of lack of mRNA information

Member
Number of introns in the 5′ non-coding region
Number of introns in the coding region
a



12


 Human
1–2
−
47 kbp (2 different transcript starts)

 Mouse
4
−
46.5 kbp

 Chicken
n.a.
b

n.a. (>1 kbp)

 African clawed frog
−
1 (N terminus)
4 kbp

 Zebrafish
n.a.
b

n.a. (>1 kbp)

 Stickleback
1
1 (TMD2)
2 kbp

 Pufferfish
n.a.
1 (TMD2)
>2 kbp

13


 Human
−
1 (rare transcript, N terminus, NM_176894) 
3.2 kp (2 different transcript starts)

 Mouse
1
−
3 kbp

 Chicken
n.a.
b

n.a. (>1 kbp)

 African clawed frog
−
1 (N terminus)
14–19 kbp

14


 Human
2
−
66 kbp (2 different transcript starts)

 Mouse
1–2
−
16 kbp

 Chicken
n.a.
b

n.a. (>1 kbp)

GPR87

 Human
1
1 (N terminus)
22.7 kbp

 Mouse
1
1 (N terminus)
16 kbp

 Chicken
2
1 (N terminus)
9.5 kbp

 African clawed frog
n.a.
b

n.a. (>1 kbp)

14
/GPR87

 Zebrafish
n.a.
b

n.a. (>1 kbp)

 Pufferfish
n.a.
b

n.a. (>1 kbp)

GPR171

 Human
2
−
5 kbp

 Mouse
1
−
4.5 kbp

 Chicken
1
−
2.3 kbp

 Zebrafish
n.a.
b

n.a. (>1 kbp)

GPR82

 Human
2
−
4 kbp

 Mouse
2–3
−
6 kbp

 Chicken
n.a.
b

n.a. (>1 kbp)

 African clawed frog
n.a.
b

n.a. (>1 kbp)

 Zebrafish
n.a.
b

n.a. (>1 kbp)

GPR34

 Human
3–4
1 cryptic (N terminus)
8.2 kbp

 Mouse
3–4
−
9.1 kbp

 Chicken
1
−
2.5 kbp

 African clawed frog
2
−
5.2 kbp

 Zebrafish

  Type 1
1
−
7.3 kbp

  Type 2
−
−
1.2 kbp

 Pufferfish
n.a.
b

n.a. (>1 kbp)



12
-like receptor members contain no intron in the coding region. However, this intronless gene structure is not well preserved in all vertebrates. The table summarizes the number of introns within the 5′ and coding region of selected vertebrate genes and estimates the size of the gene
a
Based on the 5′ longest transcript
b
Complete open reading frame within the genomic sequence but intron within the very N terminus cannot be ruled out because of lack of mRNA information



12
2
12
33
35
12
-like receptor group is, therefore, a nice example where introns were acquired in the coding region in some species during more recent evolution.
12
12
36
37
].
It is of interest to note that both genes, GPR34 and GPR82, are located in antisense orientation within a large intron of the CASK gene. This position is conserved during vertebrate evolution. The CASK gene encodes a calcium/calmodulin-dependent serine protein kinase that is a member of the membrane-associated guanylate kinase (MAGUK) protein family. Since GPR34 and GPR82 transcripts are antisense orientated to CASK one can speculate that transcripts may regulate expression of CASK or vice versa. Such hypotheses will be addressed in receptor-deficient mouse models (see below) in the future.

Key residues defining the individual member
12
1
11
38
39
33
40
42
12
12
13
14
12
3
12
12
13
12
12
K
a
K
s
12
3
12
K
a
K
s
12
Fig. 3
12
12
13
14
12
73
1.39
1.57
2.43
2.50
2.58
3.33
3.50
4.50
6.47
6.50
7.49
7.50
TMD
) are given above the sequences



Table 3
12
-like GPCR

Receptor
K
a
K
s

Pi

(mean ± SD)
(mean ± SD)


12

0.049 ± 0.018
0.145 ± 0.022

13

0.141 ± 0.070
0.187 ± 0.023

14

0.103 ± 0.036
0.190 ± 0.024

GPR87
0.046 ± 0.027
0.134 ± 0.018

GPR171
0.078 ± 0.012
0.158 ± 0.021

GPR34
0.082 ± 0.037
0.137 ± 0.026

GPR82
0.202 ± 0.049
0.167 ± 0.034



12
K
a
K
s
K
a
K
s
12
Bos taurus, Equus caballus, Canis familiaris, Pteropus vampyrus, Ornithorhynchus anatinus, Monodelphis domestica, Callithrix jacchus, Pan troglodytes, Homo sapiens, Macaca mulatta, Microcebus murinus, Pongo pygmaeus, Tarsius syrichta, Cavia porcellus, Mus musculus, Rattus norvegicus, Tursiops truncates, Gallus gallus




3
12
1.57
2.43
4.50
6.50
7.49
7.50
12
13
12
13
12
3
3.53
5.59
13
7.48
6.44
7.57
7.52
12
6.52
6.55
7.35
7.36
7.39
38
12
 but it implicates additional positions which determine ligand specificity. In-depth structure-function analysis e.g. by mutagenesis studies are required to identify key positions and their structural properties.


12
-like receptors
12
-like receptors in heterologous expression systems
12
i
22
i
13
22
24
14
43
lyso
31
33
12
15
16
44
16
13
45
q
i
Δ6qi4
46
i
47
qi4
12–14
lyso
25
33
48
].
12
lyso
33
12
4
12
14
14
14
Fig. 4
12
12
12
i
12
Δ6qi4
46
]




Saccharomyces cerevisiae
49
5
50
51
12
52
14
53
lyso
6
12
Fig. 5
i
49
Gpa
Ste4
Ste18
Ste12
Far1
 cell cycle regulator that directly inhibits the yeast cyclin-dependent kinase Cdc28-Cln



Fig. 6
12
a
12
4
b
12
−
−
12
115
177
224
115
Q mainly contributes to the constitutive activity of the triple mutant




12
1
54
12
12
12
12
115
177
224
115
6
12
-like receptors.

12
-like receptors using mouse models
12
12
2
] we only shortly summarize available data on receptor-deficient animal models.
12
1
12
12
18
55
12
12
Mus musculus castaneus
12
12
M. m. castaneus
41
12
12
M. m. castaneus
 population and favors the hypothesis of its acquisition in captivity (unpublished observations).
12
12
13
Xenopus
 genomes.
12
12
12
12
12
56
].

12
-like receptor genes within human populations
57
12
1
258
256
265
19
58
60
12
-like receptors.
12
12
61
12
62
63
64
65
4
6
12
182
12
182
12
330
12
12
 almost ruling out a specific input in receptor function.
59
158
13
158
158
Tursiops truncates
).
35
240
14
19
58
283
283
283
 has not been studied yet but it occurs naturally in the zebrafish ortholog.
46
179
355
205
205
313
296
34
].
66
12
67
70
].


Conclusion
12
12
-like receptor members. Further, one should consider combined receptor-deficient mouse models within this group but also with other P2Y receptors to uncover phenotypes which are hidden by receptor redundancy, e.g., in the case of ADP receptors.


References
1.
Fredriksson
R

Lagerstrom
MC

Lundin
LG

Schioth
HB


The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints
Mol Pharmacol
2003
63
6
1256
1272
10.1124/mol.63.6.1256

12761335


2.
Kugelgen
I


Pharmacological profiles of cloned mammalian P2Y-receptor subtypes
Pharmacol Ther
2006
110
3
415
432
10.1016/j.pharmthera.2005.08.014

16257449


3.
Jacobson
KA

Costanzi
S

Ohno
M



Molecular recognition at purine and pyrimidine nucleotide (P2) receptors
Curr Top Med Chem
2004
4
8
805
819
10.2174/1568026043450961

15078212


4.
King
BF

Townsend-Nicholson
A

Burnstock
G


Metabotropic receptors for ATP and UTP: exploring the correspondence between native and recombinant nucleotide receptors
Trends Pharmacol Sci
1998
19
12
506
514
10.1016/S0165-6147(98)01271-1

9871413


5.
Harden
TK

Lazarowski
ER

Boucher
RC


Release, metabolism and interconversion of adenine and uridine nucleotides: implications for G protein-coupled P2 receptor agonist selectivity
Trends Pharmacol Sci
1997
18
2
43
46

9090307


6.
Akbar
GK

Dasari
VR

Webb
TE



Molecular cloning of a novel P2 purinoceptor from human erythroleukemia cells
J Biol Chem
1996
271
31
18363
18367
10.1074/jbc.271.31.18363

8702478


7.
Li
Q

Schachter
JB

Harden
TK

Nicholas
RA


The 6H1 orphan receptor, claimed to be the p2y5 receptor, does not mediate nucleotide-promoted second messenger responses
Biochem Biophys Res Commun
1997
236
2
455
460
10.1006/bbrc.1997.6984

9240460


8.
Webb
TE

Kaplan
MG

Barnard
EA


Identification of 6H1 as a P2Y purinoceptor: P2Y5
Biochem Biophys Res Commun
1996
219
1
105
110
10.1006/bbrc.1996.0189

8619790


9.
Yokomizo
T

Kato
K

Terawaki
K

Izumi
T

Shimizu
T


A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders
J Exp Med
2000
192
3
421
432
10.1084/jem.192.3.421

10934230


10.
Joost P, Methner A (2002) Phylogenetic analysis of 277 human G-protein-coupled receptors as a tool for the prediction of orphan receptor ligands. Genome Biol 3(11):RESEARCH0063

11.
Nonaka
Y

Hiramoto
T

Fujita
N


Identification of endogenous surrogate ligands for human P2Y12 receptors by in silico and in vitro methods
Biochem Biophys Res Commun
2005
337
1
281
288
10.1016/j.bbrc.2005.09.052

16185654


12.
Mellor
EA

Frank
N

Soler
D



Expression of the type 2 receptor for cysteinyl leukotrienes (CysLT2R) by human mast cells: functional distinction from CysLT1R
Proc Natl Acad Sci U S A
2003
100
20
11589
11593
10.1073/pnas.2034927100

13679572


13.
Mellor
EA

Maekawa
A

Austen
KF

Boyce
JA


Cysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cells
Proc Natl Acad Sci U S A
2001
98
14
7964
7969
10.1073/pnas.141221498

11438743


14.
Mamedova
L

Capra
V

Accomazzo
MR



CysLT1 leukotriene receptor antagonists inhibit the effects of nucleotides acting at P2Y receptors
Biochem Pharmacol
2005
71
1–2
115
125
10.1016/j.bcp.2005.10.003

16280122


15.
Nomura
N

Miyajima
N

Sazuka
T



Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1
DNA Res
1994
1
1
27
35
10.1093/dnares/1.1.27

7584026


16.
Charlton
ME

Williams
AS

Fogliano
M

Sweetnam
PM

Duman
RS


The isolation and characterization of a novel G protein-coupled receptor regulated by immunologic challenge
Brain Res
1997
764
1–2
141
148
10.1016/S0006-8993(97)00438-1

9295203


17.
Chambers
JK

Macdonald
LE

Sarau
HM



A G protein-coupled receptor for UDP-glucose
J Biol Chem
2000
275
15
10767
10771
10.1074/jbc.275.15.10767

10753868


18.
Foster
CJ

Prosser
DM

Agans
JM



Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs
J Clin Invest
2001
107
12
1591
1598

11413167


19.
Hollopeter
G

Jantzen
HM

Vincent
D



Identification of the platelet ADP receptor targeted by antithrombotic drugs
Nature
2001
409
6817
202
207
10.1038/35051599

11196645


20.
Takasaki
J

Kamohara
M

Saito
T



Molecular cloning of the platelet P2T(AC) ADP receptor: pharmacological comparison with another ADP receptor, the P2Y(1) receptor
Mol Pharmacol
2001
60
3
432
439

11502873


21.
Zhang
FL

Luo
L

Gustafson
E



ADP is the cognate ligand for the orphan G protein-coupled receptor SP1999
J Biol Chem
2001
276
11
8608
8615
10.1074/jbc.M009718200

11104774


22.
Communi
D

Gonzalez
NS

Detheux
M



Identification of a novel human ADP receptor coupled to G(i)
J Biol Chem
2001
276
44
41479
41485
10.1074/jbc.M105912200

11546776


23.
Zhang
FL

Luo
L

Gustafson
E



P2Y(13): identification and characterization of a novel Galphai-coupled ADP receptor from human and mouse
J Pharmacol Exp Ther
2002
301
2
705
713
10.1124/jpet.301.2.705

11961076


24.
Marteau
F

Le Poul
E

Communi
D



Pharmacological characterization of the human P2Y13 receptor
Mol Pharmacol
2003
64
1
104
112
10.1124/mol.64.1.104

12815166


25.
Chhatriwala
M

Ravi
RG

Patel
RI

Boyer
JL

Jacobson
KA

Harden
TK


Induction of novel agonist selectivity for the ADP-activated P2Y1 receptor versus the ADP-activated P2Y12 and P2Y13 receptors by conformational constraint of an ADP analog
J Pharmacol Exp Ther
2004
311
3
1038
1043
10.1124/jpet.104.068650

15345752


26.
Marchese
A

Sawzdargo
M

Nguyen
T



Discovery of three novel orphan G-protein-coupled receptors
Genomics
1999
56
1
12
21
10.1006/geno.1998.5655

10036181


27.
Schoneberg
T

Schulz
A

Grosse
R



A novel subgroup of class I G-protein-coupled receptors
Biochim Biophys Acta
1999
1446
1–2
57
70

10395919


28.
Lee
DK

Nguyen
T

Lynch
KR



Discovery and mapping of ten novel G protein-coupled receptor genes
Gene
2001
275
1
83
91
10.1016/S0378-1119(01)00651-5

11574155


29.
Wittenberger
T

Schaller
HC

Hellebrand
S


An expressed sequence tag (EST) data mining strategy succeeding in the discovery of new G-protein coupled receptors
J Mol Biol
2001
307
3
799
813
10.1006/jmbi.2001.4520

11273702


30.
Jacobs
KA

Collins-Racie
LA

Colbert
M



A genetic selection for isolating cDNAs encoding secreted proteins
Gene
1997
198
1–2
289
296
10.1016/S0378-1119(97)00330-2

9370294


31.
Sugo
T

Tachimoto
H

Chikatsu
T



Identification of a lysophosphatidylserine receptor on mast cells
Biochem Biophys Res Commun
2006
341
4
1078
1087
10.1016/j.bbrc.2006.01.069

16460680


32.
Mombaerts
P


The human repertoire of odorant receptor genes and pseudogenes
Annu Rev Genomics Hum Genet
2001
2
493
510
10.1146/annurev.genom.2.1.493

11701659


33.
Schulz
A

Schoneberg
T


The structural evolution of a P2Y-like G-protein-coupled receptor
J Biol Chem
2003
278
37
35531
35541
10.1074/jbc.M303346200

12835326


34.
Engemaier
E

Rompler
H

Schoneberg
T

Schulz
A


Genomic and supragenomic structure of the nucleotide-like G-protein-coupled receptor GPR34
Genomics
2006
87
2
254
264
10.1016/j.ygeno.2005.10.001

16338117


35.
Roy
SW

Gilbert
W


The evolution of spliceosomal introns: patterns, puzzles and progress
Nat Rev Genet
2006
7
3
211
221

16485020


36.
Song
KY

Hwang
CK

Kim
CS



Translational repression of mouse mu opioid receptor expression via leaky scanning
Nucleic Acids Res
2007
35
5
1501
1513
10.1093/nar/gkm034

17284463


37.
Rabadan-Diehl
C

Martinez
A

Volpi
S

Subburaju
S

Aguilera
G


Inhibition of vasopressin V1b receptor translation by upstream open reading frames in the 5′-untranslated region
J Neuroendocrinol
2007
19
4
309
319
10.1111/j.1365-2826.2007.01533.x

17355321


38.
Abbracchio
MP

Boeynaems
JM

Barnard
EA



Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family
Trends Pharmacol Sci
2003
24
2
52
55
10.1016/S0165-6147(02)00038-X

12559763


39.
Costanzi
S

Mamedova
L

Gao
ZG

Jacobson
KA


Architecture of P2Y nucleotide receptors: structural comparison based on sequence analysis, mutagenesis, and homology modeling
J Med Chem
2004
47
22
5393
5404
10.1021/jm049914c

15481977


40.
Rompler
H

Schulz
A

Pitra
C



The rise and fall of the chemoattractant receptor GPR33
J Biol Chem
2005
280
35
31068
31075
10.1074/jbc.M503586200

15987686


41.
Rompler
H

Yu
HT

Arnold
A

Orth
A

Schoneberg
T


Functional consequences of naturally occurring DRY motif variants in the mammalian chemoattractant receptor GPR33
Genomics
2006
87
6
724
732
10.1016/j.ygeno.2006.02.009

16595170


42.
Sangkuhl
K

Rompler
H

Busch
W

Karges
B

Schoneberg
T


Nephrogenic diabetes insipidus caused by mutation of Tyr205: a key residue of V2 vasopressin receptor function
Hum Mutat
2005
25
5
505
10.1002/humu.9337

15841479


43.
Muller
T

Bayer
H

Myrtek
D



The P2Y14 receptor of airway epithelial cells: coupling to intracellular Ca2+ and IL-8 secretion
Am J Respir Cell Mol Biol
2005
33
6
601
609
10.1165/rcmb.2005-0181OC

16109883


44.
Offermanns
S

Simon
MI


G alpha 15 and G alpha 16 couple a wide variety of receptors to phospholipase C
J Biol Chem
1995
270
25
15175
15180
10.1074/jbc.270.25.15175

7797501


45.
Fumagalli
M

Trincavelli
L

Lecca
D

Martini
C

Ciana
P

Abbracchio
MP


Cloning, pharmacological characterisation and distribution of the rat G-protein-coupled P2Y(13) receptor
Biochem Pharmacol
2004
68
1
113
124
10.1016/j.bcp.2004.02.038

15183123


46.
Kostenis
E

Waelbroeck
M

Milligan
G


Techniques: promiscuous Galpha proteins in basic research and drug discovery
Trends Pharmacol Sci
2005
26
11
595
602
10.1016/j.tips.2005.09.007

16183138


47.
Conklin
BR

Farfel
Z

Lustig
KD

Julius
D

Bourne
HR


Substitution of three amino acids switches receptor specificity of Gq alpha to that of Gi alpha
Nature
1993
363
6426
274
276
10.1038/363274a0

8387644


48.
Ko
H

Fricks
I

Ivanov
AA

Harden
TK

Jacobson
KA


Structure-activity relationship of uridine 5′-diphosphoglucose analogues as agonists of the human P2Y14 receptor
J Med Chem
2007
50
9
2030
2039
10.1021/jm061222w

17407275


49.
Pausch
MH


G-protein-coupled receptors in Saccharomyces cerevisiae: high-throughput screening assays for drug discovery
Trends Biotechnol
1997
15
12
487
494
10.1016/S0167-7799(97)01119-0

9418303


50.
Price
LA

Kajkowski
EM

Hadcock
JR

Ozenberger
BA

Pausch
MH


Functional coupling of a mammalian somatostatin receptor to the yeast pheromone response pathway
Mol Cell Biol
1995
15
11
6188
6195

7565771


51.
Zhong
X

Malhotra
R

Guidotti
G


Regulation of yeast ectoapyrase ynd1p activity by activator subunit Vma13p of vacuolar H+-ATPase
J Biol Chem
2000
275
45
35592
35599
10.1074/jbc.M006932200

10954728


52.
Pausch
MH

Lai
M

Tseng
E

Paulsen
J

Bates
B

Kwak
S


Functional expression of human and mouse P2Y12 receptors in Saccharomyces cerevisiae
Biochem Biophys Res Commun
2004
324
1
171
177
10.1016/j.bbrc.2004.09.034

15464998


53.
Ault
AD

Broach
JR


Creation of GPCR-based chemical sensors by directed evolution in yeast
Protein Eng Des Sel
2006
19
1
1
8
10.1093/protein/gzi069

16263727


54.
Ding
Z

Kim
S

Kunapuli
SP


Identification of a potent inverse agonist at a constitutively active mutant of human P2Y12 receptor
Mol Pharmacol
2006
69
1
338
345

16234484


55.
Andre
P

Delaney
SM

LaRocca
T



P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries
J Clin Invest
2003
112
3
398
406
10.1172/JCI200317864

12897207


56.
Haynes
SE

Hollopeter
G

Yang
G



The P2Y12 receptor regulates microglial activation by extracellular nucleotides
Nat Neurosci
2006
9
12
1512
1519
10.1038/nn1805

17115040


57.
Schoneberg
T

Schulz
A

Biebermann
H

Hermsdorf
T

Rompler
H

Sangkuhl
K


Mutant G-protein-coupled receptors as a cause of human diseases
Pharmacol Ther
2004
104
3
173
206
10.1016/j.pharmthera.2004.08.008

15556674


58.
Remijn
JA

IJsseldijk
MJ

Strunk
AL



Novel molecular defect in the platelet ADP receptor P2Y12 of a patient with haemorrhagic diathesis
Clin Chem Lab Med
2007
45
2
187
189
10.1515/CCLM.2007.036

17311506


59.
Shiraga
M

Miyata
S

Kato
H



Impaired platelet function in a patient with P2Y12 deficiency caused by a mutation in the translation initiation codon
J Thromb Haemost
2005
3
10
2315
2323
10.1111/j.1538-7836.2005.01554.x

16194207


60.
Cattaneo
M

Zighetti
ML

Lombardi
R



Molecular bases of defective signal transduction in the platelet P2Y12 receptor of a patient with congenital bleeding
Proc Natl Acad Sci U S A
2003
100
4
1978
1983
10.1073/pnas.0437879100

12578987


61.
Fontana
P

Dupont
A

Gandrille
S



Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects
Circulation
2003
108
8
989
995
10.1161/01.CIR.0000085073.69189.88

12912815


62.
Fontana
P

Gaussem
P

Aiach
M

Fiessinger
JN

Emmerich
J

Reny
JL


P2Y12 H2 haplotype is associated with peripheral arterial disease: a case-control study
Circulation
2003
108
24
2971
2973
10.1161/01.CIR.0000106904.80795.35

14662702


63.
Schettert
IT

Pereira
AC

Lopes
NH

Hueb
WA

Krieger
JE


Association between platelet P2Y12 haplotype and risk of cardiovascular events in chronic coronary disease
Thromb Res
2006
118
6
679
683
10.1016/j.thromres.2005.11.009

16405973


64.
Ziegler
S

Schillinger
M

Funk
M



Association of a functional polymorphism in the clopidogrel target receptor gene, P2Y12, and the risk for ischemic cerebrovascular events in patients with peripheral artery disease
Stroke
2005
36
7
1394
1399
10.1161/01.STR.0000169922.79281.a5

15933261


65.
International HapMap Consortium

A haplotype map of the human genome
Nature
2005
437
7063
1299
1320
10.1038/nature04226

16255080


66.
Bamshad
M

Wooding
SP


Signatures of natural selection in the human genome
Nat Rev Genet
2003
4
2
99
111
10.1038/nrg999

12560807


67.
Nielsen
R

Bustamante
C

Clark
AG



A scan for positively selected genes in the genomes of humans and chimpanzees
PLoS Biol
2005
3
6
e170
10.1371/journal.pbio.0030170

15869325


68.
Nielsen
R

Williamson
S

Kim
Y

Hubisz
MJ

Clark
AG

Bustamante
C


Genomic scans for selective sweeps using SNP data
Genome Res
2005
15
11
1566
1575
10.1101/gr.4252305

16251466


69.
Tang
K

Thornton
KR

Stoneking
M


A new approach for using genome scans to detect recent positive selection in the human genome
PLoS Biol
2007
5
7
e171
10.1371/journal.pbio.0050171

17579516


70.
Kimura
R

Fujimoto
A

Tokunaga
K

Ohashi
J


A practical genome scan for population-specific strong selective sweeps that have reached fixation
PLoS ONE
2007
2
e286
10.1371/journal.pone.0000286

17356696


71.
Joensuu
T

Hamalainen
R

Lehesjoki
AE

Chapelle
A

Sankila
EM


A sequence-ready map of the Usher syndrome type III critical region on chromosome 3q
Genomics
2000
63
3
409
416
10.1006/geno.1999.6096

10704288


72.
Bedard
A

Tremblay
P

Chernomoretz
A

Vallieres
L


Identification of genes preferentially expressed by microglia and upregulated during cuprizone-induced inflammation
Glia
2007
55
8
777
789
10.1002/glia.20477

17285589


73.
Ballesteros
JA

Weinstein
H


Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors
Methods Neurosci
1995
25
366
428

Ballesteros JA, Weinstein H (1995) Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. Methods Neurosci 25:366–428 




